Friday, May 1, 2026

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

From Minerals Security Partnership to a Trade Bloc: What G7 + European Union Membership Could Cost

Analysts note a warming trend in South Korea-China relations amid U.S. efforts to restructure mineral supply chains, raising strategic choices.

Lunit’s AI Foundation Model: Transforming Healthcare with 16 Billion Parameters

Medical AI firm Lunit successfully passes the first phase of a national project and enters the second phase of nationwide validation.

Jung Eun Kim

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

How Dr. Ville is Revolutionizing Medical Knowledge Sharing for 40,000+ Doctors in 2026

Dr. Ville expands as a physician platform, offering relevant content and support, surpassing 40,000 members with significant growth in engagement.

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Osstem Implant Highlights Global Influence Through International Academic Event

Osstem Implant's "World Meeting 2026" showcased digital dentistry advancements with 1,200 global attendees, celebrating 10 years of innovation.

Revolutionary Biodegradable Stents for Pets: Meet the First Four Approved by South Korea

M.I. Tech has become the first South Korean company to receive approval for biodegradable stents for pets, addressing traditional stent complications.

Revolutionizing Stroke Treatment: How AI is Transforming Care at Korea University Anam Hospital

JLK's stroke AI solution is enhancing clinical efficiency at Korea University Anam Hospital through rapid imaging and data-driven decisions.

AI in Healthcare: AITRICS-VC Gains Approval in Indonesia – What This Means for Patients

AITRICS gains approval for its AI solution VitalCare in Indonesia, aiding early prediction of patient condition deterioration.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Discover the First-Ever 5-in-1 Calcium and Vitamin D Supplement: What You Need to Know About ‘Adtaminjeong’

Bukwang Pharmaceutical launches Edtamin Tablet, a supplement with calcium and vitamins to support nerve function and fetal development.

Hugel Partners with Hansbiomed: What Does the New ECM Product CellREDM Mean for Your Skin?

Hugel partners with HansBiomed to distribute CellREDM, enhancing skin regeneration and expanding its product portfolio in medical aesthetics.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

South Korea Government Response: Quick Solutions to Naphtha Supply Issues for Medical Materials

South Korea's government is expediting approvals for medical supply production amid naphtha supply issues, easing industry concerns.

Top News

- Our Sponsors Ad -

Follow us